Venmax Drugs and Pharmaceuticals Limited announced earnings results for the third quarter ended December 31, 2020. For the third quarter, the company announced net loss was INR 0.317 million compared to INR 1.433 million a year ago. Basic loss per share from continuing operations was INR 0.06 compared to INR 0.27 a year ago. For the nine months, total revenue was INR 1.679 million compared to INR 3.649 million a year ago. Net loss was INR 1.83 million compared to INR 1.588 million a year ago. Basic loss per share from continuing operations was INR 0.35 compared to INR 0.3 a year ago.